The U.S. Food and Drug Administration (FDA) has updated its drug shortage postings for and to reflect product availability updates, including estimated shortage duration forecasts.
Most presentations forecast supply increasing through May and June, with a return to stocking levels by July. The FDA’s postings also include a link to a from GE Healthcare’s CEO.
Bayer’s has also been added to the FDA’s Drug shortage page resulting from increased demand likely related to the GE shortage issues.
The 黑料网® (黑料网®) has developed a resource page on the contrast media shortage. For more information, please contact Gloria Romanelli, JD, 黑料网 Senior Director, Legislative and Regulatory Relations.